Literature DB >> 10996447

Evidence for a modulatory effect of sulbutiamine on glutamatergic and dopaminergic cortical transmissions in the rat brain.

F Trovero1, M Gobbi, J Weil-Fuggaza, M J Besson, D Brochet, S Pirot.   

Abstract

Chronic treatment of rats by sulbutiamine induced no change in density of N-methyl-D-aspartate (NMDA) and (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the cingular cortex, but a significant decrease of the kainate binding sites, as measured by quantitative autoradiography. In the same treated animals, an increase of D1 dopaminergic (DA) binding sites was measured both in the prefrontal and the cingular cortex, while no modification of the D2 binding sites was detected. Furthermore, an acute sulbutiamine administration induced a decrease of kainate binding sites but no change of the density of D1 and D2 DA receptors. Acute sulbutiamine injection led to a decrease of the DA levels in the prefrontal cortex and 3,4-dihydroxyphenylacetic acid levels in both the cingular and the prefrontal cortex. These observations are discussed in terms of a modulatory effect of sulbutiamine on both dopaminergic and glutamatergic cortical transmissions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996447     DOI: 10.1016/s0304-3940(00)01420-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Sulbutiamine counteracts trophic factor deprivation induced apoptotic cell death in transformed retinal ganglion cells.

Authors:  Kui Dong Kang; Aman Shah Abdul Majid; Kyung-A Kim; Kyungsu Kang; Hong Ryul Ahn; Chu Won Nho; Sang Hoon Jung
Journal:  Neurochem Res       Date:  2010-08-31       Impact factor: 3.996

2.  Transient protective effect of B-vitamins in experimental epilepsy in the mouse brain.

Authors:  Tamer Rabie; Wolfgang Mühlhofer; Thomas Bruckner; Anna Schwab; Alexander T Bauer; Manfred Zimmermann; Dieter Bonke; Hugo H Marti; Johannes Schenkel
Journal:  J Mol Neurosci       Date:  2009-09-24       Impact factor: 3.444

3.  Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.

Authors:  Marie-Laure Volvert; Sandrine Seyen; Marie Piette; Brigitte Evrard; Marjorie Gangolf; Jean-Christophe Plumier; Lucien Bettendorff
Journal:  BMC Pharmacol       Date:  2008-06-12

Review 4.  Role of the Synthetic B1 Vitamin Sulbutiamine on Health.

Authors:  Bernardo Starling-Soares; Pedro Carrera-Bastos; Lucien Bettendorff
Journal:  J Nutr Metab       Date:  2020-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.